SANOFI NSE filing

Sanofi India declares ₹75 Interim Dividend; Record Date Fixed

The RealCase readMedium impact Positive

Sanofi India declares an interim dividend of ₹75 per share with a face value of ₹10. Record date is set as 7th November 2025.

Why it matters

The dividend announcement may have a moderate impact on investor sentiment and stock price.

The market read

Declaration of dividend is generally considered a positive sign for investors.

* Sanofi India Limited has declared an interim dividend of ₹75 per equity share. * The dividend is for the year 2025, with a face value of ₹10 per share. * The record date for determining eligible members/beneficial owners is set for 7th November 2025. * The decision was made by the Board of Directors at its meeting on 29th October 2025.

Filing to action

What to do with a filing like this

Sanofi India Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sanofi India Limited. Read the original for the full detail.

View original filing